Solicitation of Nominations for Membership on the Secretary's Advisory Committee on Human Research Protections, 78660-78661 [2011-32326]
Download as PDF
78660
Federal Register / Vol. 76, No. 243 / Monday, December 19, 2011 / Notices
emcdonald on DSK5VPTVN1PROD with NOTICES
I. Background
The National Vaccine Program Office
(NVPO) is located within the Office of
the Assistant Secretary for Health
(OASH), Office of the Secretary, U.S.
Department of Health and Human
Services. NVPO provides leadership and
fosters collaboration among the various
Federal agencies involved in vaccine
and immunization activities. These
coordinated efforts are aimed to achieve
the strategic goals outlined in the
National Vaccine Plan. The National
Vaccine Plan provides a framework,
including goals, objectives, and
strategies, for pursuing the prevention of
infectious diseases through
immunizations. The NVPO also
supports the National Vaccine Advisory
Committee (NVAC). The NVAC advises
and makes recommendations to the
Assistant Secretary for Health (ASH) in
his capacity as the Director of National
Vaccine Program on matters related to
vaccine program responsibilities.
In response to historically low
influenza vaccination rates in healthcare
personnel, the ASH charged NVAC with
developing recommended strategies for
annually achieving 90% influenza
vaccination coverage among healthcare
personnel, as stated in the Healthy
People 2020 goals. The Healthcare
Personnel Influenza Vaccination
Subgroup (HCPIVS), a subgroup of the
NVAC Adult Immunization Working
Group (AWIG), was established to
address this charge on behalf of the
NVAC. The HCPIVS consists of a broad
range of stakeholders including
representatives from a variety of
medical and public health agencies and
professional organizations. The HCPIVS
members have deliberated on a number
of scientific findings, position
statements, and presentations that
examine issues pertaining to influenza
vaccination in healthcare personnel.
Through discussion and careful review,
the HCPIVS has developed draft
recommendations for consideration by
the NVAC to achieve the charge, as
noted above.
The draft report describes the
importance of influenza as a public
health issue, the importance of
protecting vulnerable patients from
influenza infection, and the importance
of influenza immunization as part of a
comprehensive influenza infection
control program for protecting both
healthcare personnel and patients
against influenza infections. From these
findings and conclusions, HCPIVS has
developed draft recommendations that
support strategies which have shown
success in improving influenza
VerDate Mar<15>2010
19:31 Dec 16, 2011
Jkt 226001
vaccination coverage among healthcare
personnel.
NVPO is seeking comments on these
draft recommendations from a variety of
stakeholders, including the general
public, for consideration by the NVAC
as they develop their final
recommendations to the ASH.
Comments received will be available for
public viewing on the NVAC Healthcare
Personnel Influenza Vaccination
Subgroup site located on the NVPO Web
site https://www.hhs.gov/nvpo/nvac/
subgroups/healthcare_personnel_
influenza_vacc_subgroup.html.
II. Request for Comment
NVPO, on behalf of the NVAC
Healthcare Personnel Influenza
Vaccination Subgroup, requests input
on the draft report and draft
recommendations https://www.hhs.gov/
nvpo/nvac/subgroups/healthcare_
personnel_influenza_vacc_subgroup.
html.
In addition to general comments,
NVPO is seeking input on additional
proven strategies and/or potential
barriers to achieving the Healthy People
2020 annual goal of 90% influenza
vaccine coverage among healthcare
personnel that are not addressed in the
NVAC Healthcare Personnel Influenza
Vaccination Subgroup draft report and
draft recommendations. Please limit
comments to 6 pages.
III. Potential Responders
NVPO invites input from a broad
range of individuals and organizations
that have interests in influenza
vaccination coverage in Healthcare
Personnel as an important patient safety
measure. Examples of potential
responders include, but are not limited
to, the following:
—General public;
—Advocacy groups and public interest
organizations;
—State and local governments;
—State and local public health
departments;
—Healthcare professional societies and
organizations;
—Healthcare organizations.
When responding, please self-identify
with any of the above or other categories
(include all that apply) and your name.
All comments submitted will be made
publicly available. Anonymous
submissions will not be considered and
will not have their comments posted.
Written submissions should not
exceed 6 pages. Any information you
submit will be made public.
Consequently, do not send proprietary,
commercial, financial, business,
confidential, trade secret, or personal
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
information that you do not wish to be
made public.
IV. Public Access
Comments on the draft report and
draft recommendations will be available
to the public on the NVPO Web site at:
https://www.hhs.gov/nvpo/nvac/
subgroups/healthcare_personnel_
influenza_vacc_subgroup.html.
You may access public comments
received by going to the above Web site.
Dated: November 07, 2011.
Bruce Gellin,
Deputy Assistant Secretary for Health,
Director, National Vaccine Program Office.
[FR Doc. 2011–32308 Filed 12–16–11; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Nominations for
Membership on the Secretary’s
Advisory Committee on Human
Research Protections
Office for Human Research
Protections, Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
Authority: 42 U.S.C. 217a, Section 222 of
the Public Health Service Act, as amended.
The Committee is governed by the provisions
of Public Law 92–463, as amended (5 U.S.C.
Appendix 2), which sets forth standards for
the formation and use of advisory
committees.
The Office for Human
Research Protections (OHRP), a program
office in the Office of the Assistant
Secretary for Health, Department of
Health and Human Services (HHS), is
seeking nominations of qualified
candidates to be considered for
appointment as members of the
Secretary’s Advisory Committee on
Human Research Protections (SACHRP).
SACHRP provides advice and
recommendations to the Secretary, HHS,
and the Assistant Secretary for Health
on matters pertaining to the continuance
and improvement of functions within
the authority of HHS directed toward
protections for human subjects in
research. SACHRP was established by
the Secretary, HHS, on October 1, 2002.
OHRP is seeking nominations of
qualified candidates to fill four
positions on the Committee membership
that will be vacated during the 2012
calendar year.
DATES: Nominations for membership on
the Committee must be received no later
than February 17, 2012.
SUMMARY:
E:\FR\FM\19DEN1.SGM
19DEN1
Federal Register / Vol. 76, No. 243 / Monday, December 19, 2011 / Notices
Nominations should be
mailed or delivered to Dr. Jerry
Menikoff, Director, Office for Human
Research Protections, Department of
Health and Human Services, 1101
Wootton Parkway, Suite 200; Rockville,
MD 20852. Nominations will not be
accepted by email or by facsimile.
FOR FURTHER INFORMATION CONTACT: Julia
Gorey, Executive Director, SACHRP,
Office for Human Research Protections,
1101 Wootton Parkway, Suite 200,
Rockville, MD 20852, telephone: (240)
453–8141. A copy of the Committee
charter and list of the current members
can be obtained by contacting Ms.
Gorey, accessing the SACHRP Web site
at https://www.hhs.gov/ohrp/sachrp, or
requesting via email at
sachrp@osophs.dhhs.gov.
SUPPLEMENTARY INFORMATION: The
Committee provides advice on matters
pertaining to the continuance and
improvement of functions within the
authority of HHS directed toward
protections for human subjects in
research. Specifically, the Committee
provides advice relating to the
responsible conduct of research
involving human subjects with
particular emphasis on special
populations such as neonates and
children, prisoners, the decisionally
impaired, pregnant women, embryos
and fetuses, individuals and
populations in international studies,
investigator conflicts of interest and
populations in which there are
individually identifiable samples, data
or information.
In addition, the Committee is
responsible for reviewing selected
ongoing work and planned activities of
the OHRP and other offices/agencies
within HHS responsible for human
subjects protection. These evaluations
may include, but are not limited to, a
review of assurance systems, the
application of minimal research risk
standards, the granting of waivers,
education programs sponsored by
OHRP, and the ongoing monitoring and
oversight of institutional review boards
and the institutions that sponsor
research.
Nominations: The OHRP is requesting
nominations to fill four positions for
voting members of SACHRP. Two
positions will become vacant in July
and two in October, 2012. Nominations
of potential candidates for consideration
are being sought from a wide array of
fields, including, but not limited to:
Public health and medicine, behavioral
and social sciences, health
administration, and biomedical ethics.
To qualify for consideration of
appointment to the Committee, an
emcdonald on DSK5VPTVN1PROD with NOTICES
ADDRESSES:
VerDate Mar<15>2010
19:31 Dec 16, 2011
Jkt 226001
individual must possess demonstrated
experience and expertise in any of the
several disciplines and fields pertinent
to human subjects protection and/or
clinical research.
The individuals selected for
appointment to the Committee can be
invited to serve a term of up to four
years. Committee members receive a
stipend and reimbursement for per diem
and any travel expenses incurred for
attending Committee meetings and/or
conducting other business in the
interest of the Committee. Interested
applicants may self-nominate.
Nominations should be typewritten.
The following information should be
included in the package of material
submitted for each individual being
nominated for consideration: (1) A letter
of nomination that clearly states the
name and affiliation of the nominee, the
basis for the nomination (i.e., specific
attributes which qualify the nominee for
service in this capacity), and a statement
that the nominee is willing to serve as
a member of the Committee; (2) the
nominator’s name, address, daytime
telephone number, and the home and/
or work address, telephone number, and
email address of the individual being
nominated; and (3) a current copy of the
nominee’s curriculum vitae. Federal
employees should not be nominated for
consideration of appointment to this
Committee.
The Department makes every effort to
ensure that the membership of HHS
Federal advisory committees is fairly
balanced in terms of points of view
represented and the committee’s
function. Every effort is made to ensure
that individuals from a broad
representation of geographic areas,
women and men, ethnic and minority
groups, and the disabled are given
consideration for membership on HHS
Federal advisory committees.
Appointment to this Committee shall be
made without discrimination on the
basis of age, race, ethnicity, gender,
sexual orientation, disability, and
cultural, religious, or socioeconomic
status.
Individuals who are selected to be
considered for appointment will be
required to provide detailed information
regarding their financial holdings,
consultancies, and research grants or
contracts. Disclosure of this information
is necessary in order to determine if the
selected candidate is involved in any
activity that may pose a potential
conflict with the official duties to be
performed as a member of SACHRP.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
78661
Dated: December 12, 2011.
Jerry Menikoff,
Director, Office for Human Research
Protections, Executive Secretary, Secretary’s
Advisory Committee on Human Research
Protections.
[FR Doc. 2011–32326 Filed 12–16–11; 8:45 am]
BILLING CODE 4150–36–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[CDC–2011–0014]
Correction for Draft Vieques Report:
An Evaluation of Environmental,
Biological, and Health Data From the
Island of Vieques, PR
Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (DHHS).
ACTION: General notice: correction.
AGENCY:
On December 12, 2011 the
Agency for Toxic Substance and Disease
Register published a 30-day public
comment period notice in the Federal
Register (76 FR 77234) for the Draft
Vieques Report: An Evaluation of
Environmental, Biological, and Health
Data From the Island of Vieques, Puerto
Rico.’’ This comment period was
published as closing on January 11,
2012 in error. The comment period will
be open for 90 days and will close
March 11, 2012.
DATES: Written comments must be
received on or before March 12, 2012.
Electronic comments may be sent via
https://www.regulations.gov, docket
control number CDC–2011–0014. Please
follow the directions on the site to
submit comments. Comments may also
be sent to the attention of Rolanda
Morrison, ATSDR Records Center,
Mailstop F–09, 4770 Buford Highway
NE., Atlanta, GA 30341. Send one copy
of all comments and three copies of all
supporting documents. Comments may
also be submitted by email to
ATSDRecordsCenter@cdc.gov. Please
ensure docket control number CDC–
2011–0014 is included in the subject
line of all written correspondence.
Because all public comments regarding
this draft report are available for public
inspection, no confidential business
information or other confidential
information should be submitted in
response to this notice.
FOR FURTHER INFORMATION CONTACT: The
Division of Health Assessment and
Consultation, Agency for Toxic
Substances and Disease Registry,
SUMMARY:
E:\FR\FM\19DEN1.SGM
19DEN1
Agencies
[Federal Register Volume 76, Number 243 (Monday, December 19, 2011)]
[Notices]
[Pages 78660-78661]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-32326]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Nominations for Membership on the Secretary's
Advisory Committee on Human Research Protections
AGENCY: Office for Human Research Protections, Office of the Assistant
Secretary for Health, Office of the Secretary, Department of Health and
Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
Authority: 42 U.S.C. 217a, Section 222 of the Public Health
Service Act, as amended. The Committee is governed by the provisions
of Public Law 92-463, as amended (5 U.S.C. Appendix 2), which sets
forth standards for the formation and use of advisory committees.
SUMMARY: The Office for Human Research Protections (OHRP), a program
office in the Office of the Assistant Secretary for Health, Department
of Health and Human Services (HHS), is seeking nominations of qualified
candidates to be considered for appointment as members of the
Secretary's Advisory Committee on Human Research Protections (SACHRP).
SACHRP provides advice and recommendations to the Secretary, HHS, and
the Assistant Secretary for Health on matters pertaining to the
continuance and improvement of functions within the authority of HHS
directed toward protections for human subjects in research. SACHRP was
established by the Secretary, HHS, on October 1, 2002. OHRP is seeking
nominations of qualified candidates to fill four positions on the
Committee membership that will be vacated during the 2012 calendar
year.
DATES: Nominations for membership on the Committee must be received no
later than February 17, 2012.
[[Page 78661]]
ADDRESSES: Nominations should be mailed or delivered to Dr. Jerry
Menikoff, Director, Office for Human Research Protections, Department
of Health and Human Services, 1101 Wootton Parkway, Suite 200;
Rockville, MD 20852. Nominations will not be accepted by email or by
facsimile.
FOR FURTHER INFORMATION CONTACT: Julia Gorey, Executive Director,
SACHRP, Office for Human Research Protections, 1101 Wootton Parkway,
Suite 200, Rockville, MD 20852, telephone: (240) 453-8141. A copy of
the Committee charter and list of the current members can be obtained
by contacting Ms. Gorey, accessing the SACHRP Web site at https://www.hhs.gov/ohrp/sachrp, or requesting via email at
sachrp@osophs.dhhs.gov.
SUPPLEMENTARY INFORMATION: The Committee provides advice on matters
pertaining to the continuance and improvement of functions within the
authority of HHS directed toward protections for human subjects in
research. Specifically, the Committee provides advice relating to the
responsible conduct of research involving human subjects with
particular emphasis on special populations such as neonates and
children, prisoners, the decisionally impaired, pregnant women, embryos
and fetuses, individuals and populations in international studies,
investigator conflicts of interest and populations in which there are
individually identifiable samples, data or information.
In addition, the Committee is responsible for reviewing selected
ongoing work and planned activities of the OHRP and other offices/
agencies within HHS responsible for human subjects protection. These
evaluations may include, but are not limited to, a review of assurance
systems, the application of minimal research risk standards, the
granting of waivers, education programs sponsored by OHRP, and the
ongoing monitoring and oversight of institutional review boards and the
institutions that sponsor research.
Nominations: The OHRP is requesting nominations to fill four
positions for voting members of SACHRP. Two positions will become
vacant in July and two in October, 2012. Nominations of potential
candidates for consideration are being sought from a wide array of
fields, including, but not limited to: Public health and medicine,
behavioral and social sciences, health administration, and biomedical
ethics. To qualify for consideration of appointment to the Committee,
an individual must possess demonstrated experience and expertise in any
of the several disciplines and fields pertinent to human subjects
protection and/or clinical research.
The individuals selected for appointment to the Committee can be
invited to serve a term of up to four years. Committee members receive
a stipend and reimbursement for per diem and any travel expenses
incurred for attending Committee meetings and/or conducting other
business in the interest of the Committee. Interested applicants may
self-nominate.
Nominations should be typewritten. The following information should
be included in the package of material submitted for each individual
being nominated for consideration: (1) A letter of nomination that
clearly states the name and affiliation of the nominee, the basis for
the nomination (i.e., specific attributes which qualify the nominee for
service in this capacity), and a statement that the nominee is willing
to serve as a member of the Committee; (2) the nominator's name,
address, daytime telephone number, and the home and/or work address,
telephone number, and email address of the individual being nominated;
and (3) a current copy of the nominee's curriculum vitae. Federal
employees should not be nominated for consideration of appointment to
this Committee.
The Department makes every effort to ensure that the membership of
HHS Federal advisory committees is fairly balanced in terms of points
of view represented and the committee's function. Every effort is made
to ensure that individuals from a broad representation of geographic
areas, women and men, ethnic and minority groups, and the disabled are
given consideration for membership on HHS Federal advisory committees.
Appointment to this Committee shall be made without discrimination on
the basis of age, race, ethnicity, gender, sexual orientation,
disability, and cultural, religious, or socioeconomic status.
Individuals who are selected to be considered for appointment will
be required to provide detailed information regarding their financial
holdings, consultancies, and research grants or contracts. Disclosure
of this information is necessary in order to determine if the selected
candidate is involved in any activity that may pose a potential
conflict with the official duties to be performed as a member of
SACHRP.
Dated: December 12, 2011.
Jerry Menikoff,
Director, Office for Human Research Protections, Executive Secretary,
Secretary's Advisory Committee on Human Research Protections.
[FR Doc. 2011-32326 Filed 12-16-11; 8:45 am]
BILLING CODE 4150-36-P